Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Interest Coverage Ratio (2022 - 2025)

Atara Biotherapeutics' Interest Coverage Ratio history spans 4 years, with the latest figure at 35.3 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio fell 194.15% year-over-year to 35.3; the TTM value through Dec 2025 reached 1.81, up 110.02%, while the annual FY2025 figure was 1.81, 110.02% up from the prior year.
  • Interest Coverage Ratio reached 35.3 in Q4 2025 per ATRA's latest filing, down from 3.93 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 38.15 in Q1 2025 to a low of 22055.0 in Q1 2022.
  • Average Interest Coverage Ratio over 4 years is 1494.77, with a median of 42.6 recorded in 2023.
  • The largest YoY upside for Interest Coverage Ratio was 240.78% in 2025 against a maximum downside of 194.15% in 2025.
  • A 4-year view of Interest Coverage Ratio shows it stood at 645.63 in 2022, then surged by 92.1% to 50.99 in 2023, then surged by 76.47% to 12.0 in 2024, then crashed by 194.15% to 35.3 in 2025.
  • Per Business Quant, the three most recent readings for ATRA's Interest Coverage Ratio are 35.3 (Q4 2025), 3.93 (Q3 2025), and 3.29 (Q2 2025).